Efficacy and Safety of Linperlisib in Relapsed/Refractory Large Granular T Lymphocytic Leukemia

NCT06224257 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

41

Enrollment

OTHER

Sponsor class

Conditions

Relapsed/Refractory Large Granular T Lymphocytic Leukemia

Interventions

DRUG: Linperlisib

Sponsor

Institute of Hematology & Blood Diseases Hospital, China

Collaborators

[object Object]